Drugs and Therapy Perspectives
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.6 | Q4 | 4.2% | 0.204 | Q3 | 28.7% |
| 2024 | 0.7 | Q4 | 8.5% | 0.232 | Q3 | 36.6% |
| 2023 | 0.6 | Q4 | 9.5% | 0.188 | Q3 | 32.9% |
| 2022 | 1.2 | 17.5% | 0.162 | Q4 | 30.9% | |
| 2021 | — | 24.0% | 0.161 | Q4 | 32.6% | |
| 2020 | — | — | 0.127 | Q4 | 14.4% | |
| 2019 | — | — | 0.115 | Q4 | 15.6% | |
| 2018 | — | — | 0.131 | Q4 | 15.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1172-0360
ISSN
1179-1977
region
Western Europe
coverage
1993-2026